Joaquim Cabral, PhD, DSc
Full Professor of Instituto Superior Técnico (IST), University of Lisbon, Portugal "Bioengineering Challenges for Stem Cell-based Therapies and Regenerative Medicine"
Plenary Lecture III @ 9 am, 11th March 2022
|
BioJoaquim M S Cabral is a Distinguished Full Professor of Instituto Superior Técnico (IST), University of Lisbon, Portugal. He was the Head (2004-2010) of the Chemical and Biological Engineering Founding Head (2011) of Department of Bioengineering, the Founding Director (2013) of the Institute for Bioengineering and Biosciences at IST and the Founding Coordinator (2021) of the new Associate Laboratory Institute for Health and Bioeconomy. He holds a Diploma in Chemical Engineering (1976), PhD (1982) and Habilitation (1988) from IST. Post-doctoral study at Massachusetts Institute of Technology (1983-4); faculty positions: Assistant (1983-6), Associate (1986-91) and Full Professor (1992). He was the first Distinguished Professor (2015) at IST.
Since 1984, Joaquim Cabral launched new courses, including Enzyme Engineering, Separation and Purification Processes of Biological Products, Introduction of Biological Engineering, Cell and Tissue Engineering and Organ Engineering in different curricula at IST. He was one of the founders of: Specialization/Branch of Biotechnology of the Chemical Engineering Diploma Course (5 years) (1984); MSc in Biotechnology: Biochemical Engineering (1986); the Biological Engineering Diploma Course (5 years) (1999); and MSc Bioengineering and Nanosystems (2008) at IST. He was the coordinator (2007-2012) of the MIT-Portugal PhD Program in Bioengineering Systems. He is the coordinator (2007-) of the PhD program at IST. In 2021 he created the new MSc Bioengineering in Regenerative and Precision Medicine at IST. Joaquim Cabral has authored more than 600 original research articles, review articles, book chapters and books in biotechnology, bioprocess engineering and stem cell engineering with 14 thousand citations (WoS h index 56). His lab-Stem Cell Engineering Research Groupis focused on cell production platforms for the ex-vivo expansion of stem cells and/or their controlled differentiation into specific cell types and micro-tissues, as well as their integration with bioseparation and high-resolution purification technologies. |